← All educational resources

Starter Stacks by Condition: The Order, the Forms, the Labs, and the Stop Rules, on One Page

2026-11-22

Same post, two depths. Switch any time; the research version has the enzyme names, lab markers, and doses. Written from a research and education perspective: a model of what may be going on and what the published literature suggests would address it if the model is right, not medical advice or a treatment plan.

Every mechanism post on this site ends with a list of levers. People have asked for the short version: for a given picture, what is the order, which forms and brands, what gets tested first, and when do you stop. This page is that, for the six pictures I am asked about most. It is a research-based starting sequence for a conversation with your clinician, not a prescription; the reasoning behind each item lives in the linked post, and the one-page protocol cards are printable from each.

The rules that apply to every stack

  1. Labs before supplements, for anything that can be measured. Iron, vitamin D, B12, magnesium, and thyroid all have a test, and the test decides the dose and whether to start at all. The lab guide here.
  2. One new thing a week. If something goes wrong, you know what did it. The supplement sequencing worksheet here is the printable for this.
  3. Lowest dose first, then up. Most reactions are dose reactions.
  4. Food first where the food works. Liver for iron and B vitamins, sardines for omega-3, eggs for choline, seeds for magnesium; the food-sources table here.
  5. The stop rules are real. A supplement that makes you worse for more than three days is stopped, not pushed through.
  6. Pregnancy, planning, and breastfeeding remove alpha-lipoic acid, high-dose anything, and most herbs from every stack below, and move the whole conversation to the obstetric provider.
  7. Medications first. The medications table here shows what your prescriptions drain and what they interact with; berberine, St. John's wort, 5-HTP, and high-dose fish oil are the common interaction sources.

Brands named are the ones used on this site for form and quality (Seeking Health, Thorne, Carlson, Jarrow, Kirkman, Procapsin, Dr. Mercola liposomal C, Vital Proteins); equivalents in the same form are fine. Links on the favorite products page (my favorite products).

POTS and dysautonomia

Full reasoning: the pots post here.

Order What Form and dose Why Stop or adjust if
Week 0 Labs Ferritin, saturation, CRP; MMA; RBC magnesium; whole-blood thiamine; vitamin D; standing heart rate Sets the doses below
Week 0 Salt and fluid 6 to 10 g sodium daily, 2 to 3 L fluid, salt in the first glass; waist-high compression upright Volume Blood pressure high, swelling, kidney or heart disease (clinician first)
Week 1 Magnesium Malate (Seeking Health) 300 to 400 mg elemental, split, larger at night Autonomic calm, cofactor Loose stools (switch to glycinate), low blood pressure worsens
Week 2 Fish oil Carlson, 2 g EPA+DHA with a meal Nerve membranes, inflammation Bleeding risk, blood thinners (clinician)
Week 3 Creatine and phosphatidylcholine Creatine 3 to 5 g; PC 1 to 2 g Methyl-sparing before any methyl donor Cramping (hydrate), reflux
Week 4 B12 Hydroxocobalamin plus adenosylcobalamin, sublingual, 1 to 2 mg Nerve repair; MMA decides Acne, anxiety (lower dose)
Week 5 Thiamine Benfotiamine 150 to 300 mg or thiamine HCl 100 to 300 mg Autonomic nerves, PDH Rare: headache, insomnia (take in the morning)
Week 6 Iron, only if ferritin under 50 and saturation under 45 Bisglycinate 25 to 50 mg every other morning with vitamin C Dopamine, oxygen, thyroid Saturation over 45, CRP high, constipation
Week 8 Mito stack CoQ10 (ubiquinol) 100 to 200 mg; ALCAR 500 to 1,000 mg; ALA 300 to 600 mg (no ALA in pregnancy, planning, breastfeeding) Energy Insomnia from ALCAR (morning only), GI upset
Week 9 Liposomal vitamin C Dr. Mercola, 1 g Collagen, catecholamines, mast cells Oxalate stones, loose stools
Week 10 Apigenin 50 mg at bedtime GABA, mast cells, sleep Grogginess
Ongoing Recumbent exercise, HRV tracking, slow breathing 4 in 6 out Retrain the autopilot Post-exertional crash: drop the volume
Week 12 Recheck Standing heart rate, ferritin, MMA, homocysteine

Low-histamine trial in week 2 to 6 if you flush or react to food.

Mast cell activation and histamine

Full reasoning: the mast cell post here and the 3am post here.

Order What Form and dose Why Stop or adjust if
Week 0 Labs Plasma heparin, 24-hour urinary N-methylhistamine and PGD2 metabolite (cold), chromogranin A; copper, ceruloplasmin, zinc; vitamin D; stool and breath testing Markers that actually turn positive
Week 1 to 4 Low-histamine trial The four-week trial here, freeze-same-day rule, log Removes the dietary load Weight loss, under-eating
Week 1 DAO Seeking Health DAO Block or equivalent, 10,000 to 20,000 HDU before meals Degrades dietary histamine No change by week 3 (bacterial histamine likely; see SIBO)
Week 2 Vitamin C Liposomal 1 g, or 500 mg twice daily DAO cofactor, histamine breakdown Oxalate issues
Week 3 Quercetin (day) and apigenin (night) Quercetin 500 mg twice daily with meals; apigenin 50 mg at bedtime Mast cell stabilization Quercetin can worsen slow-COMT people (headache, anxiety); keep it in the day
Week 4 B6 and copper P5P 25 mg; copper 1 to 2 mg if low DAO and HNMT cofactors B6 over 50 mg (nerve risk)
Week 5 Creatine and PC, then methylation support As in POTS; then methylfolate 200 to 400 mcg or SAMe 200 mg only if homocysteine is high or symptoms track methylation HNMT clearance Over-stimulation, insomnia (slow COMT)
Week 6 Magnesium, fish oil As in POTS
Week 7 Gut Kirkman Biofilm Defense before antimicrobials if SIBO confirmed; the SIBO post here Bacterial histamine Clinician-directed
Through a clinician H1 (cetirizine or fexofenadine) plus H2 (famotidine); ketotifen or cromolyn Receptor blockade and stabilization
Week 12 Recheck Symptom log, markers at 3 months

Fatigue and mitochondrial strain

Full reasoning: the connective tissue post here, the metabolic slide here, the ferritin post here, and the low T3 post here.

Order What Form and dose Why Stop or adjust if
Week 0 Labs Ferritin panel, MMA, RBC magnesium, thiamine, vitamin D, full thyroid, fasting insulin, organic acids Most fatigue is one of these
Week 0 Food Protein 1.2 to 1.6 g/kg; substrate separation here; no grazing; alcohol out Fuel conversion Under-eating
Week 1 Magnesium As above
Week 2 Thiamine Benfotiamine 150 to 300 mg PDH gate
Week 3 B12 Hydroxo plus adenosyl
Week 4 Iron if indicated As above
Week 5 Riboflavin 100 to 400 mg Fat oxidation, MAO, MTHFR Bright urine (harmless)
Week 6 CoQ10 Ubiquinol 100 to 200 mg with fat Electron transport
Week 7 ALCAR 500 to 1,000 mg morning Fat into mitochondria Insomnia, agitation
Week 8 ALA 300 to 600 mg (excluded in pregnancy, planning, breastfeeding) PDH, glutathione Hypoglycemia symptoms, thiamine must be adequate first
Week 9 Creatine 3 to 5 g Energy buffer, methyl-sparing
Week 10 Selenium and zinc if T3 is low Selenium 100 to 200 mcg; zinc 15 to 25 mg with copper Thyroid conversion Over 200 mcg selenium
Ongoing Resistance training 2 to 3 times weekly, walk after meals, sleep Post-exertional malaise: pace, do not push
Week 12 Recheck Full panel

Migraine

Full reasoning: the migraine post here.

Order What Form and dose Why Stop or adjust if
Week 0 Labs and diary RBC magnesium, ferritin panel, vitamin D, homocysteine, fasting insulin; 3-month diary
Week 0 Regular meals, fixed wake time, caffeine steady and low Threshold
Week 1 Magnesium 400 to 600 mg elemental, divided; glycinate or malate Grade A Loose stools
Week 2 Riboflavin 400 mg Grade B; 3 months to judge
Week 3 CoQ10 100 mg three times daily Grade B
Week 4 Low-histamine trial and DAO if attacks follow wine, cheese, leftovers, or the cycle
Week 5 Omega-3 1.5 g EPA+DHA Grade B
Week 6 Vitamin D, iron, folate and B12 where low
Week 7 Feverfew or ginger Feverfew standardized extract; ginger 250 mg at onset Grade B Butterbur avoided (liver)
Through a clinician Perimenstrual magnesium loading, triptan mini-prophylaxis, CGRP agents, the preventive classes
Week 12 Recheck Monthly migraine days; 50 percent reduction is the target

Anxiety with a body signature

Full reasoning: the anxiety post here and the neurotransmitter map here.

Order What Form and dose Why Stop or adjust if
Week 0 Labs and log Ferritin panel, thyroid, RBC magnesium, P5P, fasting insulin, MMA, vitamin D; 2-week log with meal timing and posture Which of the twelve
Week 0 Free levers Protein breakfast, no sugar-only snacks, caffeine before noon or none, alcohol out, slow breathing twice daily, fixed wake time Clears half the list
Week 1 Magnesium glycinate 300 to 400 mg, larger dose at night NMDA brake, GAD cofactor
Week 2 P5P and zinc P5P 25 to 50 mg; zinc 15 to 25 mg with copper GABA factory B6 over 50 mg long term
Week 3 Glycine or taurine at night Glycine 3 g; taurine 1 to 2 g Inhibitory tone
Week 4 Apigenin or theanine Apigenin 50 mg at bedtime; theanine 200 mg as needed GABA
Week 5 Iron, vitamin D, B12 where low
Week 5 Low-histamine trial if the histamine signature fits; stand test if the autonomic signature fits
Avoid 5-HTP or St. John's wort with any serotonergic medication; stimulant stacking; methyl donors in slow COMT without low-dose titration
Week 12 Recheck GAD-7 against the log; panel

Hypermobility, connective tissue, and the triad

Full reasoning: the connective tissue post here.

Order What Form and dose Why Stop or adjust if
Week 0 Labs Homocysteine, MMA, RBC glutathione, ferritin panel, copper and ceruloplasmin, RBC magnesium, vitamin D The shared budget
Week 1 Magnesium As above
Week 2 Vitamin C Liposomal 1 g, or 500 mg twice daily Collagen cross-linking Oxalate
Week 3 Collagen peptides Vital Proteins 10 to 15 g with the vitamin C Glycine, proline Histamine reaction (switch to glycine alone)
Week 4 Creatine and PC As above Methyl-sparing
Week 5 B12 and folate (folinic or methyl at low dose) only if homocysteine or MMA is high Methylation debt Over-stimulation
Week 6 Fish oil 2 g EPA+DHA
Week 7 Mito stack CoQ10, ALCAR, ALA as above ROS load
Week 8 Tocotrienols Procapsin, 100 to 200 mg Antioxidant
Week 9 Copper (if low), zinc with copper Copper 1 to 2 mg; zinc 15 mg Lysyl oxidase Copper high or ceruloplasmin high
Ongoing Isometric then progressive loading; POTS and MCAS stacks as they apply; no fluoroquinolones
Week 12 Recheck Homocysteine, MMA, glutathione, ferritin, copper; activity window

What this page is not

A protocol, a prescription, or a substitute for finding the cause. Each table assumes you have read the post it comes from, have the labs, and have a clinician who knows what you are taking. If a stack is not producing a measurable change by week 12, the model is wrong for you and the next step is a different model, not a bigger stack.

Educational content written from a research perspective, not medical advice. I am a PhD scientist, not a physician, and I do not diagnose, treat, cure, or prevent disease. Doses are research-range adult doses for discussion with your clinician; they are not individualized recommendations. Iron is never started without ferritin, saturation, and CRP.

Why the sequence is the intervention

The plain version carries the tables; this version carries the reasons the order is what it is, the interactions that matter, and the monitoring that converts a stack from a hopeful list into a testable one. The general principles:

  1. Measure before replacing for every analyte with a validated marker (ferritin with saturation and CRP; MMA and holotranscobalamin; RBC magnesium; whole-blood TPP; 25-OH vitamin D; plasma PLP; copper and ceruloplasmin; thyroid panel). Empirical supplementation of iron, copper, selenium, iodine, and pyridoxine carries specific harm.
  2. Serial introduction (one agent per 5 to 7 days) permits attribution of adverse effects and of benefit; it is the n-of-1 design applied to supplementation. The sequencing worksheet here is the printable instrument.
  3. Cofactor order follows pathway dependence. Magnesium precedes vitamin D (CYP27B1 and CYP2R1 are magnesium-dependent); thiamine precedes alpha-lipoic acid (ALA increases PDH flux and can unmask thiamine insufficiency); creatine and phosphatidylcholine precede methyl donors (creatine synthesis via GAMT and PC synthesis via PEMT together consume roughly 70 percent of SAMe, so supplying them reduces methyl demand before adding supply); copper status precedes zinc; iron precedes thyroid re-evaluation (TPO and DIO1 are iron-dependent).
  4. Dose escalation from the low end, since most adverse reactions are dose-dependent (GI effects of magnesium, activation from B12 and ALCAR, over-stimulation from methyl donors in COMT Met/Met carriers).
  5. Stop rules are pre-specified: worsening beyond 72 hours, a new symptom, or a marker moving the wrong direction.
  6. Reproductive exclusions: alpha-lipoic acid (insufficient safety data, this site's convention), high-dose vitamin A, most botanicals, and berberine are withheld in pregnancy, conception planning, and lactation; iodine and selenium are kept within RDA ranges.
  7. Drug interactions reviewed first (the medications table here): anticoagulants with omega-3 and vitamin E; serotonergic drugs with 5-HTP, tryptophan, SAMe, and St. John's wort; CYP3A4 and CYP2D6 substrates with berberine, quercetin (modest CYP inhibition and COMT inhibition), and CBD; levothyroxine with calcium, iron, and magnesium (4-hour separation); methotrexate with folate forms; MAOIs with tyrosine and tyramine.

Phenotype notes

POTS and dysautonomia

Rationale: the small fiber model (the pots post here): volume and vasoconstrictive support first (sodium 6 to 10 g, fluid 2 to 3 L, compression; Grade B in the HRS and CCS statements), then the nerve-repair substrate in order of evidence and safety (magnesium, omega-3, B12 as hydroxocobalamin plus adenosylcobalamin, thiamine), then iron if indicated (iron deficiency raises orthostatic tachycardia), then mitochondrial cofactors. Head-of-bed elevation is not used on this site. Interactions: sodium loading is contraindicated in hypertension, heart failure, and renal disease; fludrocortisone, midodrine, ivabradine, and pyridostigmine are clinician agents that interact with the volume strategy. Monitoring: standing heart rate increment monthly; ferritin, MMA, homocysteine at 12 weeks; morning HRV as a daily pacing signal. Expected timescale: 3 to 9 months for small fiber regeneration.

Mast cell activation

Rationale: mediator testing that detects activation (plasma heparin after venous occlusion, urinary N-methylhistamine and 2,3-dinor-11-beta-PGF2-alpha, chromogranin A; tryptase and histamine are usually normal; the heparin and prostaglandin post here), dietary load reduction (the low-histamine trial here), degradation support (DAO, vitamin C, PLP, copper), stabilization (quercetin by day for its COMT and MAO inhibition, which some Met/Met carriers tolerate poorly at night; apigenin at night as a benzodiazepine-site ligand), then methylation support only when indicated, because HNMT is SAMe-dependent but methyl donors over-stimulate a subset. Interactions: quercetin with CYP3A4 and P-glycoprotein substrates; cromolyn and ketotifen are clinician agents; DAO products are porcine-derived (dietary restriction relevance). Monitoring: daily symptom log; mediators at 3 months; stool and breath testing, since enteric histamine production from dysbiosis is a common reason the diet plateaus (the SIBO post here).

Fatigue with mitochondrial strain

Rationale: substrate conversion before cofactor loading (the metabolic slide here); thiamine before lipoate; riboflavin for the acyl-CoA dehydrogenases, ETF, MAO, and MTHFR; CoQ10 as ubiquinol with fat; ALCAR in the morning (activating); creatine as both energy buffer and methyl-sparer. Statins deplete CoQ10; valproate depletes carnitine; metformin depletes B12. Monitoring: organic acids (lactate, pyruvate, ethylmalonate, dicarboxylics, MMA) at baseline and 12 weeks; thyroid panel re-read after iron and selenium repletion; post-exertional malaise frequency as the pacing signal, since exercise prescription in PEM phenotypes follows pacing, not graded exposure (NICE NG206).

Migraine

Rationale: the three Grade A to B nutrients (magnesium, riboflavin, CoQ10) in that order because magnesium has the fastest effect and the broadest safety; a minimum 12-week trial for riboflavin and CoQ10 before judging; histamine and estrogen levers by phenotype; iron, vitamin D, and one-carbon status corrected where low (homocysteine is elevated in migraine with aura; folate, B6, B12 reduced frequency in MTHFR 677T carriers in a randomized trial). Butterbur withdrawn from recommendation (hepatotoxic pyrrolizidine alkaloids in non-certified products). Interactions: magnesium with bisphosphonates, quinolones, and tetracyclines (spacing); feverfew with anticoagulants; triptans with SSRIs (low serotonin syndrome risk, monitored). Monitoring: monthly migraine days and acute medication days (medication-overuse headache threshold: 10 or more triptan or combination days, 15 or more simple analgesic days per month); 50 percent responder definition at 12 weeks.

Anxiety with somatic drivers

Rationale: the twelve-cause differential (the anxiety post here); cost-free levers first because glycemic and caffeine causes are the most common and resolve within a week; GABA-pathway cofactors (magnesium, PLP, zinc) next; inhibitory amino acids and apigenin or theanine as symptomatic support; iron, vitamin D, and B12 by marker; diagnostic trials (low-histamine, active stand) where the signature fits. Interactions: 5-HTP, tryptophan, SAMe, and Hypericum are withheld with any serotonergic medication; methyl donors titrated from 100 to 200 mcg in COMT Met/Met carriers; PLP bounded at 50 mg with plasma monitoring; kava and phenibut are not used. Monitoring: GAD-7 against the log at 4, 8, 12 weeks; HRV; standing heart rate.

Hypermobility and the triad

Rationale: the shared budget (the connective tissue post here): collagen substrate and cofactors (ascorbate, glycine and proline from peptides, copper for lysyl oxidase, iron for the hydroxylases), methyl-sparing before methyl supply, ROS load reduction (mitochondrial cofactors, tocotrienols, glutathione precursors), and the POTS and MCAS stacks as they apply. Collagen peptides are a histamine load for some (switch to glycine 3 g). Interactions: vitamin C raises iron absorption (relevant where HFE variants are present); copper is withheld where ceruloplasmin is elevated (estrogen, inflammation) until the free copper picture is clear. Fluoroquinolones avoided (the fluoroquinolone post here). Monitoring: homocysteine, MMA, RBC glutathione, ferritin, copper at 12 weeks; a weekly activity-window log; isometric before progressive loading.

When a stack has failed

Absence of measurable change in the pre-specified markers and the symptom log at 12 weeks is a negative result for the model, not an indication for dose escalation. The next step is a different hypothesis: the differential pages on this site (the anxiety post, the SIBO post, the low T3 post, the ferritin post, the small fiber neuropathy post here), or a clinician-directed investigation the nutritional model cannot replace.

Educational and research content, not medical advice. The author holds a PhD in cellular and molecular nutrition, is not a licensed physician, and does not diagnose, treat, cure, or prevent disease. Doses are adult research ranges for discussion with a clinician who knows the person's medications and history; they are not individualized recommendations.